ZNF213

Across TCGA pan-cancer cohorts, ZNF213 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated ZNF213 data layer compared with 23 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher ZNF213 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF213 expression acts as an unfavorable survival marker.

THYM, HNSC, and COAD are the cancer types where ZNF213 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
HNSC	OS	Median	All	0.198	0.768	.001	21	view →
COAD	DFS	Median	All	0.393	0.693	.012	15	view →
LUSC	OS	Median	II,III,IV	0.192	0.615	.010	12	view →
OV	DFS	Median	III,IV	0.182	0.532	.014	6	view →
GBM	OS	Median	All	0.121	0.415	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

ZNF213–THYM (OS)

Open the THYM breakdown →